Today4d
FDA expands approval of breast cancer drug Kisqali: What to know
The FDA expanded approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease. The decision will free up access to the medication for tens of ...
FDA expands approval of breast cancer drug Kisqali to earlier-stage patients
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat ...
Dem Sen. Bob Casey still airing ‘disrespectful’ ad featuring Jamal Khashoggi despite widow’s pleas
The TV ad was still airing on networks in Philadelphia, Harrisburg and Scranton as of Thursday, upsetting Hanan Elatr ...
With TV Drug Ads, What You See Is Not Necessarily What You Get
The U.S. is one of only two countries that legally allows drugmakers to advertise products directly to patients. There are ...
Monthly Prescribing Reference4d
Kisqali Approved for HR-Positive, HER2-Negative Early Breast Cancer
“We continue to transform cancer care with Kisqali, building on its established profile in the metastatic setting and now helping a wide range of people as they strive to stay cancer-free ...
MarketWatch6d
Novartis' Kisqali Reduces Breast Cancer Recurrence by Nearly One-Third, Trials Show
Novartis said that its Kisqali drug reduces the risk of breast cancer recurrence by nearly one-third, in updated analysis from Phase 3 trials. The Swiss pharmaceutical company said Monday that its ...
UPI4d
FDA expands use of Kisqali to early stage breast cancer patients
Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease, following the U.S. Food and Drug Administration's expanded approval of the treatment ...
NBC DFW5d
FDA expands approval of breast cancer drug Kisqali to earlier stage patients
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease, drugmaker Novartis said Tuesday.